TGFB1 and neoplasm: For example, PTEN and CASP8 act as tumor suppressors [23], whereas STAT3, MYC, EGFR, and TGFB1 are canonical oncogenic drivers implicated in cell cycle progression, stemness, and therapy resistance, particularly in triple-negative BC [24,25].